Clinicopathological and molecular features of colorectal cancer with synchronous adenoma

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Henley SJ, Ward EM, Scott S, et al. Annual report to the nation on the status of cancer, part I: National cancer statistics. cancer-am cancer soc. Cancer. 2020;126(10):2225–2249.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding SA, et al. Colorectal cancer statistics. CA Cancer J Clin. 2020;70(3):145–164.
   PubMed Web of Science ®Google Scholar
• Li S, Zhu K, Yu W, et al. Synchronous neoplastic lesions in referred patients with colorectal cancer: a retrospective cohort study. CMAR. 2019;11:9951–9959.
   Google Scholar
• Park JH, Moon HS, Kwon IS, et al. Quality of preoperative colonoscopy afects missed postoperative adenoma detection in colorectal cancer patients. Dig Dis Sci. 2020;65(7):2063–2070.
   PubMed Web of Science ®Google Scholar
• Pinol V, Andreu M, Castells A, et al. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors. Dis Colon Rectum. 2004;47(7):1192–1200.
   PubMed Web of Science ®Google Scholar
• Flor N, Ceretti AP, Luigiano C, et al. Performance of CT colonography in diagnosis of synchronous colonic lesions in patients with occlusive colorectal cancer. AJR Am J Roentgenol. 2020;214(2):348–354.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang ZG, Song C, et al. Clinical research of synchronous colorectal neoplasms. Zhonghua Wai Ke Za Zhi. 2006;44(21):1498–1500.
   PubMedGoogle Scholar
• Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112(1):24–28.
   PubMed Web of Science ®Google Scholar
• Rijn JC, Reitsma JB, Stoker J, et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterology. 2006;101(2):343–350.
   PubMed Web of Science ®Google Scholar
• Seo JH, Lee BI, Lee K, et al. Adenoma miss rate of polypectomy-referring hospitals is high in Korea. Korean J Intern Med. 2020;35(4):881–888.
   PubMed Web of Science ®Google Scholar
• Zimmermann FK, Sehner S, Rex DK, et al. Right-Sided location not associated with missed colorectal adenomas in an individual-level reanalysis of tandem colonoscopy studies. Gastroenterology. 2019; 157(3):660–671.
   PubMed Web of Science ®Google Scholar
• Jung Y, Joo YE, Kim HG, et al. Relationship between the endoscopic withdrawal time and adenoma/polyp detection rate in individual colonic segments: a KASID multicenter study. Gastrointest Endosc. 2019;89(3):523–530.
   PubMed Web of Science ®Google Scholar
• Shirin H, Shpak B, Epshtein J, et al. G-EYE colonoscopy is superior to standard colonoscopy for increasing adenoma detection rate: an international randomized controlled trial (with videos). Gastrointest Endosc. 2019;89(3):545–553.
   PubMed Web of Science ®Google Scholar
• Clercq CM, Winkens B, Bakker CM, et al. Metachronous colorectal cancers result from missed lesions and non-compliance with surveillance. Gastrointest Endosc. 2015;82(2):325–333.
   PubMed Web of Science ®Google Scholar
• Zhao S, Wang S, Pan P, et al. Magnitude, Risk factors, and factors associated with adenoma miss rate of tandem colonoscopy: a systematic review and meta-analysis. Gastroenterology. 2019;156(6):1661–1674.
   PubMed Web of Science ®Google Scholar
• Bogaert J, Prenen H. Molecular genetics of colorectal cancer. Ann Gastroenterol. 2014;27(1):9–14.
   PubMedGoogle Scholar
• Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012; 107(9):1315–1329.
   PubMed Web of Science ®Google Scholar
• Palma F, D’Argenio V, Pol J, et al. The molecular hallmarks of the serrated pathway in colorectal cancer. Cancers (Basel). 2019;11(7):1017.
   Web of Science ®Google Scholar
• Warren S, Gates O. Carcinoma of ceruminous gland. Am J Pathol. 1941; 17(6):821–826.
   PubMedGoogle Scholar
• CD-02. International classification of diseases for oncology. Geneva: World Health Organisation; 1992.
   Google Scholar
• Myer PA, Mannalithara A, Singh G, et al. Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy. Gastroenterology. 2012;143(5):1227–1236.
   PubMed Web of Science ®Google Scholar
• Amin MB, Edge S, Greene F, et al. editors. AJCC cancer staging manual. Vol 8. New York: Springer; 2017.
   Google Scholar
• Gupta S, Lieberman D, Anderson JC, et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the us multi-society Task Force on Colorectal Cancer. Gastrointest Endosc. 2020;91(3):463–485.
   PubMed Web of Science ®Google Scholar
• Cairns SR, Scholefield JH, Steele RJ, et al.; Association of Coloproctology for Great Britain and Ireland. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666–689.
   PubMed Web of Science ®Google Scholar
• Borda A, Martinez-Penuela JM, Munoz-Navas M, et al. Synchronous neoplastic lesions in colorectal cancer. An analysis of possible risk factors favouring presentation. Rev Esp Enferm Dig. 2008;100(3):139–145.
   PubMed Web of Science ®Google Scholar
• Patel A, Williams N, Parsons N, et al. Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer. Int J Colorectal Dis. 2017;32(11):1609–1616.
   PubMed Web of Science ®Google Scholar
• Samadder NJ, Curtin K, Wong J, et al. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah. Clin Gastroenterol Hepatol. 2014; 12(12):2078–2084.
   PubMed Web of Science ®Google Scholar
• Han X, Qian W, Liu Y, et al. The effect of age, sex and pathologic type on risk of multiple polyps in a chinese teaching hospital based study. J Dig Dis. 2020. DOI:10.1111/1751-2980.12863
   Web of Science ®Google Scholar
• Carr PR, Weigl K, Edelmann D, et al. Estimation of absolute risk of colorectal cancer based on healthy lifestyle, genetic risk, and colonoscopy status in a population-based study. Gastroenterology. 2020. DOI:10.1111/1751-2980.12863
   PubMedGoogle Scholar
• Klein WMP, Jacobsen PB, Helzlsouer KJ. Alcohol and cancer risk: clinical and research implications. JAMA. 2020;323(1):23–24.
   PubMed Web of Science ®Google Scholar
• Sinicrope F, Sargent D. Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res. 2012;18(6):1506–1512.
   PubMed Web of Science ®Google Scholar
• Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6):2073–2087.
   PubMed Web of Science ®Google Scholar
• Gong Q, Zhang HH, Sun SB, et al. Mismatch repair-deficient status associates with favorable prognosis of eastern Chinese population with sporadic colorectal cancer. Oncol Lett. 2018;15(5):7007–7013.
   PubMed Web of Science ®Google Scholar
• Deng Z, Qin Y, Wang J, et al. Prognostic and predictive role of DNA mismatch repair status in stage II-III colorectal cancer: a systematic review and meta-analysis. Clin Genet. 2020;97(1):25–38.
   PubMed Web of Science ®Google Scholar
• Hampel H, Frankel W, Martin E, et al. Screening for the lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352(18):1851–1860.
   PubMed Web of Science ®Google Scholar
• Aaltonen L, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338(21):1481–1487.
   PubMed Web of Science ®Google Scholar
• Sinicrope FA, Mahoney MR, Smyrk TC, et al. Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy. JCO. 2013;31(29):3664–3672.
   PubMed Web of Science ®Google Scholar
• Nora A, Nelly A, Ghada S, et al. Microsatellite instability and life style factors in sporadic colorectal cancer. Asian Pac J Cancer Prev. 2020;21(5):1471–1480.
   Google Scholar
• Giovanni CP, Gianpaolo S, Silverio T. K-ras mutations and cetuximab in colorectal cancer. N Engl J Med. 2009;360(8):833–836.
   PubMedGoogle Scholar
• Messner I, Cadeddu G, Huckenbeck W, et al. KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines. J Cancer Res Clin Oncol. 2013;139(2):201–209.
   PubMed Web of Science ®Google Scholar
• Smeby J, Sveen A, Merok MA, et al. CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer. Annals of Oncology. 2018;29(5):1227–1234.
   PubMed Web of Science ®Google Scholar
• Gallo G, Sena G, Vescio G, et al. The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review. Ann Ital Chir. 2019;90:127–137.
   PubMed Web of Science ®Google Scholar
• Ye JX, Liu Y, Qin Y, et al. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients. WJG. 2015;21(5):1595–1605.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu J, Wang L, et al. HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China. Peerj. 2020;8:e8602.
   PubMed Web of Science ®Google Scholar
• Umeda Y, Nagasaka T, Mori Y, et al. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability. J Hepatobiliary Pancreat Sci. 2013;20(2):223–233.
   PubMed Web of Science ®Google Scholar
• Nazemalhosseini-Mojarad E, Kishani Farahani R, Mehrizi M, et al. Prognostic value of BRAF and KRAS mutation in relation to colorectal cancer survival in Iranian patients: correlated to microsatellite instability. J Gastrointest Cancer. 2020;51(1):53–62.
   PubMed Web of Science ®Google Scholar
• De Roock W, Claes B, Bernasconi D, et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol. 2010;11(8):753–762.
   PubMed Web of Science ®Google Scholar
• Zhu L, Dong C, Cao Y, et al. Prognostic role of braf mutation in stage ii/iii colorectal cancer receiving curative resection and adjuvant chemotherapy: A meta-analysis based on randomized clinical trials. Plos One. 2016;11(5):e0154795.
   PubMed Web of Science ®Google Scholar
• Kopetz S, Grothey A, Yaeger R, et al. Encorafenib, binimetinib, and cetuximab in braf v600e-mutated colorectal cancer. N Engl J Med. 2020;382(9):876–877.
   Google Scholar
• Chika N, Eguchi H, Kumamoto K, et al. Prevalence of lynch syndrome and lynch-like syndrome among patients with colorectal cancer in a Japanese hospital-based population. JPN J Clin Oncol. 2017;47(2):108–117.
   PubMed Web of Science ®Google Scholar
• Peter Z, Stephen M, Marlene S, et al. Molecular genetic changes in benign colorectal tumors synchronous with microsatellite unstable carcinomas do not support a field defect. Int J Mol Epidemiol Genet. 2017;8(3):27–39.
   PubMed Web of Science ®Google Scholar
• Rosa I, Fidalgo P, Chaves P, et al. The co-localization of carcinomas and adenomas favors a regional field defect in the colon: an observational study. Int J Colorectal Dis. 2015;30(3):323–327.
   PubMed Web of Science ®Google Scholar
• Lian J, Ma L, Yang J, et al. Aberrant gene expression profile of unaffected colon mucosa from patients with unifocal colon polyp. Med Sci Monit. 2015;21:3935–3940.
   PubMed Web of Science ®Google Scholar
• Horvat N, Raj A, Ward JM, et al. Clinical value of CT colonography versus preoperative colonoscopy in the surgical management of occlusive colorectal cancer. AJR Am J Roentgenol. 2018;210(2):333–340.
   PubMed Web of Science ®Google Scholar
• Russo M, Crisafulli G, Sogari A, et al. Adaptive mutability of colorectal cancers in response to targeted therapies. Science. 2019;366(6472):1473–1480.
   PubMed Web of Science ®Google Scholar
• Phipps AI, Alwers E, Harrison T, et al. Association between molecular subtypes of colorectal tumors and patient survival, based on pooled analysis of 7 international studies. Gastroenterology. 2020;158(8):2158–2168.
   PubMed Web of Science ®Google Scholar